$225 Million is the total value of Kopp Family Office, LLC's 12 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 7.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEO | Sell | NeoGenomics Inc. | $106,259,000 | -35.9% | 2,203,165 | -28.4% | 47.22% | -30.1% |
| HZNP | Buy | Horizon Therapeutics Public Limited Company | $50,325,000 | +57.4% | 546,775 | +25.1% | 22.36% | +71.8% |
| VCEL | Sell | Vericel Corporation | $31,890,000 | -10.3% | 574,080 | -50.1% | 14.17% | -2.1% |
| IEFA | Buy | ISHARES TRcore msci eafe | $13,122,000 | +16100.0% | 182,128 | +15360.8% | 5.83% | +17569.7% |
| IEMG | Buy | ISHARES TRcore msci emkt | $12,664,000 | +63220.0% | 196,766 | +62167.7% | 5.63% | +70250.0% |
| FIVN | Five9, Inc. | $10,400,000 | -10.4% | 66,525 | 0.0% | 4.62% | -2.2% | |
| IVV | ISHARES TRcore s&p500 etf | $116,000 | +5.5% | 292 | 0.0% | 0.05% | +15.6% | |
| ISTB | ISHARES TRcore 1 5 yr usd | $105,000 | -0.9% | 2,050 | 0.0% | 0.05% | +9.3% | |
| IAGG | ISHARES TRcore intl aggr | $43,000 | -2.3% | 783 | 0.0% | 0.02% | +5.6% | |
| IMTB | ISHARES TRcr 5 10 yr etf | $39,000 | -2.5% | 764 | 0.0% | 0.02% | +6.2% | |
| IJH | ISHARES TRcore s&p mcp etf | $38,000 | +11.8% | 147 | 0.0% | 0.02% | +21.4% | |
| IJR | ISHARES TRcore s&p scp etf | $22,000 | +15.8% | 207 | 0.0% | 0.01% | +25.0% | |
| XENT | Exit | Intersect ENT Inc. | $0 | – | -10,000 | -100.0% | -0.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 16 | Q3 2023 | 90.1% |
| Vericel Corporation | 16 | Q3 2023 | 14.5% |
| Five9, Inc. | 16 | Q3 2023 | 11.2% |
| ISHARES TR | 13 | Q3 2023 | 16.7% |
| ISHARES TR | 13 | Q3 2023 | 10.6% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
View Kopp Family Office, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| RTI Surgical Holdings, Inc. | July 07, 2020 | ? | ? |
| NEOGENOMICS INC | January 07, 2020 | 4,844,625 | 4.6% |
| OCLARO, INC. | January 04, 2019 | ? | ? |
| SUPERCONDUCTOR TECHNOLOGIES INC | October 05, 2018 | ? | ? |
View Kopp Family Office, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-16 |
View Kopp Family Office, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.